Active Surveillance - When Can You Continue Watching and When Do You Intervene?
Guilherme Godoy, MD, MPH; Dov Kadmon, MD; and Michael A. Brooks, MD, explore active surveillance best practices for patients with prostate cancer.
Guilherme Godoy, MD, MPH; Dov Kadmon, MD; and Michael A. Brooks, MD, explore active surveillance best practices for patients with prostate cancer.
Пікірлер: 2
Low risk cancer? Do you leave it be or RP?
Intervention with PIRAD 2-3 with 9.5 mm lesion on 3T MRI with prostate density at 0.063? Biopsy was not recommended on the male age 66 with BPH.